← All Sponsors
SPONSOR

JenKem Technology Co., Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Glioblastoma Multiforme (GBM)
NCT06595186 Phase 2
Recruiting

JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme (GBM)
China View Trial →